Cleared Traditional

K100427 - FORA GW 9014 TELEHEALTH GATEWAY/TD-9014 TELEHEALTH GATEWAY

K100427 is an FDA 510(k) clearance for FORA GW 9014 TELEHEALTH GATEWAY/TD-9014..., manufactured by Taidoc Technology Corporation. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 101-day FDA review.

K100427 · Taidoc Technology Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
101d
Days
Class 2
Risk

K100427 is an FDA 510(k) clearance for the FORA GW 9014 TELEHEALTH GATEWAY/TD-9014 TELEHEALTH GATEWAY. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Taidoc Technology Corporation (New Taipei City, TW). The FDA issued a Cleared decision on May 28, 2010 after a review of 101 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Taidoc Technology Corporation devices

FDA 510(k) Submission Details - K100427

510(k) Number K100427 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 2010
Decision Date May 28, 2010
Days to Decision 101 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 125d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 120
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K100427.
WALDO PATIENT MONITOR
K110334 · Waldo Health · Apr 2011
INTEL HEALTH GUIDE
K103276 · Intel Corporation Digital Health Group · Feb 2011
3M LITTMANN SCOPE-TO SCOPE SOFTWARE SYSTEM
K101834 · 3M Company · Sep 2010
SAVI WIRELESS, MODEL PM500
K091696 · Medicomp, Inc. · Oct 2009
HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM
K090610 · Hospira, Inc. · Mar 2009
FORA TELEHEALTH SYSTEM
K083046 · Taidoc Technology Corporation · Jan 2009